SCHEMBL30842214

SCHEMBL30842214

CCN(Cc1nc2cnc3cc(Br)ccc3c2n1CCOCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 7/20 0.39
▸ TLR8 Q9NR97 2/20 0.39
▸ NLRP3 Q96P20 1/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ TSPO P30536 2/20 0.34
▸ MMP1 P03956 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20476287 1.00 TLR7 (0.39) TLR7TLR8NLRP3L3MBTL1TSPO
SCHEMBL26863050 0.88 NLRP3 (0.42) TLR7TLR8NLRP3L3MBTL1
SCHEMBL30842239 0.87 TLR7 (0.55) TLR7TLR8NLRP3
SCHEMBL20741453 0.87 TLR7 (0.55) TLR7TLR8NLRP3
SCHEMBL20741457 0.86 TLR7 (0.36) TLR7TLR8NLRP3L3MBTL1TSPO
SCHEMBL20741497 0.85 NLRP3 (0.43) TLR7TLR8NLRP3L3MBTL1TSPO
SCHEMBL30842206 0.85 NLRP3 (0.43) TLR7TLR8NLRP3L3MBTL1TSPO
SCHEMBL29920814 0.81 TSPO (0.39) TLR7NLRP3L3MBTL1TSPOMMP1
SCHEMBL21949797 0.81 TSPO (0.39) TLR7NLRP3L3MBTL1TSPOMMP1
SCHEMBL20475956 0.77 TLR7 (0.62) TLR7TLR8NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110325534-B Substituted imidazoquinolines as NLRP3 modulators 先天肿瘤免疫公司 2024-04-05 — — CN disclosed
Send feedback